
SGO On the Go
83 FOLLOWERS
SGO On the Go is the Society of Gynecologic Oncology's best education for the busy clinician. Join us for discussions regarding clinical practice, advances in research, and other compelling topics relevant to gynecologic oncology.
SGO On the Go
1M ago
This is the last of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Mirvetuximab soravtansine. The panel discusses personal clinical experiences and lessons learned. When to dose adjust and hold or even discontinue Mirvetuximab soravtansine. Once again, the session ends with take home points for patient monitoring while on Mirvetuximab soravtansine.
2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall ..read more
SGO On the Go
1M ago
This is the second of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of Mirvetuximab soravtansine. Focusing on eye drop prescriptions, home medications, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.
2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD
Judith A. Smith, B.S., Pha ..read more
SGO On the Go
1M ago
This is the first of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. After going over some general information on Mirvetuximab soravtansine including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of APP, Optometrist, and Gynecologic Oncologist educated and prepared for giving Mirvetuximab soravtansine. The session wraps up with some key take home points on Mirvetuximab soravtansine.
2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD
Ju ..read more
SGO On the Go
3M ago
The goal of this podcast is to follow-up Key Concepts of enhanced recovery after surgery (ERAS), and This podcast is divided into sections referring to pre-operative, intraoperative, and postoperative considerations. We hope to provide some practical tips on how to develop a successful ERAS program at your institution. We acknowledge that all health systems are a little different. Yet there are some common strategies that can be used in developing collaborations. In conclusion, how to implement ERAS is to foster communication between various team members, including the patient. We hope t ..read more
SGO On the Go
3M ago
Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Yasmin Lyons, DO and Lisa Rauh, MD discuss the best cervical, vulvar and vaginal cancer when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and joining a study group, visiting the SGO ConnectEd, meeting with your local radiation oncologist to discuss radiation in general and your individual patients managed, knowing landmark trials for prognostic factors (GOG 36), surgery for early-stage vulvar ca ..read more
SGO On the Go
4M ago
Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Anna Beavis, MD and Robert Neff, MD discuss the best ovarian cancer resources on surgical considerations, chemotherapy, and genetic testing when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and grouping your cases to see their similarities/differences, management of toxicities of common targeted therapies for gynecologic cancers, the benefits of joining a study group, attending the SGO Annual Meeting ..read more
SGO On the Go
4M ago
Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Anna Beavis, MD and Robert Neff, MD discuss the best cervix, vaginal, and vulvar cancer resources on surgical considerations, chemotherapy, and genetic testing when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and grouping your cases to see their similarities/differences, management of toxicities of common targeted therapies for gynecologic cancers, the benefits of joining a study group, attending the ..read more
SGO On the Go
4M ago
Listen to Tracilyn Hall, MD, co-chair of the SGO Taskforce for Board Certification Support, interview Claire Hoppenot, MD and Alexander Melamed, MD discussing the best resources for Uterine Malignancies and GTD Considerations when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding reviewing for the ABOG Gynecology Oncology Certifying Exam. They will help you reference the ABOG bulletin, resources on the SGO ConnectEd website, as well as relevant studies. In addition to this podcast, the taskforce will offer other informative ..read more
SGO On the Go
4M ago
Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Anna Beavis, MD and Robert Neff, MD discuss the best ovarian cancer resources on surgical considerations, chemotherapy, and genetic testing when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and grouping your cases to see their similarities/differences, management of toxicities of common targeted therapies for gynecologic cancers, the benefits of joining a study group, attending the SGO Annual Meeting ..read more
SGO On the Go
4M ago
This is the last of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Lenvatinib/pembrolizumab. The panel discusses personal clinical experiences and lessons learned. When to dose adjust and hold or even discontinue Lenvatinib/pembrolizumab. Once again, the session ends with take home points for patient monitoring while on Lenvatinib/pembrolizumab.
2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, M ..read more